Amanda Baines

437 total citations
15 papers, 320 citations indexed

About

Amanda Baines is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Amanda Baines has authored 15 papers receiving a total of 320 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Physiology, 6 papers in Pulmonary and Respiratory Medicine and 3 papers in Molecular Biology. Recurrent topics in Amanda Baines's work include Asthma and respiratory diseases (8 papers), Inhalation and Respiratory Drug Delivery (4 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (4 papers). Amanda Baines is often cited by papers focused on Asthma and respiratory diseases (8 papers), Inhalation and Respiratory Drug Delivery (4 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (4 papers). Amanda Baines collaborates with scholars based in United Kingdom, United States and New Zealand. Amanda Baines's co-authors include Praveen Anand, Thor Ostenfeld, Robert Lai, Boris A. Chizh, Ravikiran Shenoy, Jonathan Robertson, Nick Bird, Joanne Palmer, Jonathan Bullman and Alok Krishen and has published in prestigious journals such as Blood, Respiratory Medicine and Respiratory Research.

In The Last Decade

Amanda Baines

14 papers receiving 312 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amanda Baines United Kingdom 7 199 96 83 50 37 15 320
Changbin Ke China 10 142 0.7× 141 1.5× 24 0.3× 76 1.5× 39 1.1× 31 322
Eun-Sung Park South Korea 5 163 0.8× 248 2.6× 113 1.4× 76 1.5× 75 2.0× 7 492
Natalie A. Duggett United Kingdom 7 212 1.1× 107 1.1× 42 0.5× 81 1.6× 203 5.5× 7 453
Emma Levine United States 9 158 0.8× 93 1.0× 46 0.6× 106 2.1× 84 2.3× 14 412
Ronnie The Phong Trinh United States 7 94 0.5× 114 1.2× 16 0.2× 47 0.9× 44 1.2× 8 239
Natalie Yuen United States 8 83 0.4× 190 2.0× 32 0.4× 49 1.0× 31 0.8× 17 426
H.W. Jin Japan 9 207 1.0× 114 1.2× 24 0.3× 100 2.0× 159 4.3× 11 411
Rachel Barker United Kingdom 10 209 1.1× 142 1.5× 36 0.4× 42 0.8× 74 2.0× 18 470
Ruifang Dong China 10 64 0.3× 212 2.2× 112 1.3× 25 0.5× 73 2.0× 16 422

Countries citing papers authored by Amanda Baines

Since Specialization
Citations

This map shows the geographic impact of Amanda Baines's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amanda Baines with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amanda Baines more than expected).

Fields of papers citing papers by Amanda Baines

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amanda Baines. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amanda Baines. The network helps show where Amanda Baines may publish in the future.

Co-authorship network of co-authors of Amanda Baines

This figure shows the co-authorship network connecting the top 25 collaborators of Amanda Baines. A scholar is included among the top collaborators of Amanda Baines based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amanda Baines. Amanda Baines is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
2.
Liu, Joyce F., Stéphanie Gaillard, Andrea E. Wahner Hendrickson, et al.. (2024). Niraparib, Dostarlimab, and Bevacizumab as Combination Therapy in Pretreated, Advanced Platinum-Resistant Ovarian Cancer: Findings From Cohort A of the OPAL Phase II Trial. JCO Precision Oncology. 8(8). e2300693–e2300693. 6 indexed citations
3.
4.
5.
6.
Bardsley, George, Peter T. Daley‐Yates, Amanda Baines, et al.. (2018). Anti-inflammatory duration of action of fluticasone furoate/vilanterol trifenatate in asthma: a cross-over randomised controlled trial. Respiratory Research. 19(1). 133–133. 14 indexed citations
7.
8.
Kempsford, Rodger, et al.. (2016). The efficacy of fluticasone furoate administered in the morning or evening is comparable in patients with persistent asthma. Respiratory Medicine. 112. 18–24. 6 indexed citations
9.
Braithwaite, Irene, Mathew Williams, Sharon Power, et al.. (2016). Randomised, double-blind, placebo-controlled, cross-over single dose study of the bronchodilator duration of action of combination fluticasone furoate/vilanterol inhaler in adult asthma. Respiratory Medicine. 119. 115–121. 8 indexed citations
10.
Prime, David, Wilfried De Backer, Melanie Hamilton, et al.. (2015). Effect of Disease Severity in Asthma and Chronic Obstructive Pulmonary Disease on Inhaler-Specific Inhalation Profiles Through the ELLIPTA ® Dry Powder Inhaler. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 28(6). 486–497. 49 indexed citations
11.
12.
Anand, Praveen, Ravikiran Shenoy, Joanne Palmer, et al.. (2011). Clinical trial of the p38 MAP kinase inhibitor dilmapimod in neuropathic pain following nerve injury. European Journal of Pain. 15(10). 1040–1048. 133 indexed citations
13.
Palmer, James A., Robert Lai, Nicola Thomas, et al.. (2009). 701 RANDOMISED, PLACEBO‐CONTROLLED, PARALLEL‐GROUP STUDY OF THE EFFECT OF SB‐705498, A TRPV1 RECEPTOR ANTAGONIST, ON PAIN FOLLOWING THIRD MOLAR TOOTH EXTRACTION. European Journal of Pain. 13(S1). 1 indexed citations
14.
Chizh, B.A., James A. Palmer, Robert Lai, et al.. (2009). 702 A RANDOMISED, TWO‐PERIOD CROSS‐OVER STUDY TO INVESTIGATE THE EFFICACY OF THE TRPV1 ANTAGONIST SB‐705498 IN ACUTE MIGRAINE. European Journal of Pain. 13(S1). 20 indexed citations
15.
Baines, Amanda, et al.. (1984). Pilot clinical trial with a new beta 2-sympathomimetic bronchodilator, mabuterol.. PubMed. 34(11A). 1697–8. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Changbin Ke Breakdown of academic impact, for papers by Eun-Sung Park Breakdown of academic impact, for papers by Natalie A. Duggett Breakdown of academic impact, for papers by Emma Levine Breakdown of academic impact, for papers by Ronnie The Phong Trinh Breakdown of academic impact, for papers by Natalie Yuen Breakdown of academic impact, for papers by H.W. Jin Breakdown of academic impact, for papers by Rachel Barker Breakdown of academic impact, for papers by Ruifang Dong
Rankless by CCL
2026